Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00723853 · ClinicalTrials.gov registry record · NA
REACH-OUT: Chicago Children's Diabetes Prevention Program
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
NCT00723853: Completed NA study, sponsored by University of Chicago.
NCT00723853 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 131 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00723853, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate two nutrition and exercise programs in children ages 9-12 who are at risk for developing type 2 diabetes. This study also includes the involvement of parents or guardians who are willing to participate in these programs with the child.
Interventions
- BEHAVIORAL Reach-Out Program, nutritional and exercise program
- BEHAVIORAL Reach-In Program, standard of care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-04 |
| Phase | NA |
What the finished NCT00723853 record still lists
NCT00723853 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Reach-Out Program, nutritional and exercise program is the first listed.
NCT00723853 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00723853 about?
NCT00723853 is a clinical study titled "REACH-OUT: Chicago Children's Diabetes Prevention Program". The purpose of this research study is to evaluate two nutrition and exercise programs in children ages 9-12 who are at risk for developing type 2 diabetes. This study also includes the involvement of parents or guardians who are willing to participate in these programs with the child.
What is the current status of trial NCT00723853?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2008-04. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00723853?
The interventions under investigation include: Reach-Out Program, nutritional and exercise program (BEHAVIORAL), Reach-In Program, standard of care (BEHAVIORAL).
Who is sponsoring clinical trial NCT00723853?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00723853's enrollment target sits among peer trials
131 732nd of 2000 higher than 1,268 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia